{
    "doi": "https://doi.org/10.1182/blood-2021-147236",
    "article_title": "ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19 ",
    "article_date": "November 5, 2021",
    "session_type": "904.Outcomes Research-Non-Malignant Conditions",
    "abstract_text": "PV, NR and MMP contributed equally Introduction Patients with red blood cell disorders (RBCD), chronic life threating multisystemic disorders in their severe forms, are likely to be at increased risk of complications from SARS-Cov-2 (Covid-19), but evidence in this population is scarce due to its low frequency and heterogeneous distribution. ERN-EuroBloodNet, the European Reference Network in rare hematological disorders, established a European registry to determine the impact of COVID-19 on RBCD patients and identify risk factors predicting severe outcomes. Methods The ERN-EuroBloodNet registry was established in March 2020 by Vall d'Hebron Research Institute based on REDcap software in accordance with the Regulation (EU) 2016/679 on personal data. The local Research Ethics Committee confirmed that the exceptional case of the pandemic justifies the waiver of informed consent. The ERN-EuroBloodNet registry on RBCD and COVID-19 is endorsed by the European Hematology Association (EHA). Eligible patients had confirmed RBCD and COVID-19. Data collected included demographics, diagnosis, comorbidities, treatments, and COVID-19 (severity grade, clinical manifestations, acute events, treatments, hospitalization, intensive care unit, death). For analysis of COVID-19 severity, two groups were established 1) Mild: asymptomatic or mild symptoms without clinical pneumonia and 2) Severe: pneumonia requiring oxygen/respiratory support and/or admission to intensive care unit. Continuous variables were compared using the Wilcoxon rank-sum test or Kruskall Wallis test, while categorical variables were analyzed using the Chi-square test or Fisher's Exact test. Relevant factors influencing disease or severity were examined by the logistic regression adjusted for age. Results As of June 2021, 42 medical centers from 10 EU countries had registered 373 patients: 191 Sickle cell disease (SCD), 156 Thalassemia major and intermedia (THAL) and 26 other RBCD. 84% of the SCD patients were reported by Spain, Belgium, Italy and The Netherlands and 92% of the THAL patients by Italy and Greece. The mean age of SCD was lower (22.5y) than of THAL (39.6y) with pediatric population accounting for 50.5% in SCD and 9% in THAL (p <0.001). Splenectomy and comorbidities were higher in THAL (51.3% and 65.8%) than in SCD (16% and 48.1%) (p<0.001, p=0.002). Age and BMI correlated with COVID-19 severity, as described in the general population (p=0.002, p<0.001). Fig 1 shows age distribution and COVID-19 severity by disease severity groups. The mean age for severe COVID-19 was lower in patients with severe SCD (SS/SB0 vs SC/SB+: 23.3y vs 67.5y) and THAL (major vs intermedia: 43.5 vs 51.3y) (p<0.001). Potential risk factors such as elevated ferritin, current chelation or history of splenectomy did not confer additional risk for developing severe COVID-19 in any patient group. Only diabetes as a comorbidity correlated with severity grade in SCD (p=0.011) and hypertension in THAL (p=0.014). While severe COVID-19 infection in SCD was associated with both ACS (p<0.001) and kidney failure requiring treatment (p=0.001), this was not predicted by a history of previous ACS or kidney disease in steady state. Overall, 14.8% RBC patients needed oxygen/respiratory support, 4.4% were admitted to ICU with an overall mortality rate of 0.8% (no deaths were registered in pediatric age), much lower than reported in other similar cohorts. Discussion Results obtained so far show that severe COVID-19 occurs at younger ages in more aggressive forms of SCD and THAL. Current preventive approaches (shielding, vaccinations) focus on age over disease severity. Our data highlights the risk of severe COVID-19 infection in some young patients, particularly those with SS/SB0 SCD, suggesting that immunization should be considered in this pediatric group as well. Results between similar sized cohorts of RBCD patients vary between each other and those presented here, highlighting the importance of collecting all of these small cohorts together to ensure adequate statistical power so that definitive risk factors (eg. age, genotype, comorbidities) can be reliably identified and used to guide management of patients with these rare disorders in the light of the ongoing pandemic. Figure 1 View large Download slide Figure 1 View large Download slide Close modal Disclosures Longo:  Bristol Myers Squibb: Honoraria; BlueBird Bio: Honoraria. Bard\u00f3n-Cancho:  Novartis Oncology Spain: Research Funding. Flevari:  PROTAGONIST COMPANY: Research Funding; ADDMEDICA: Consultancy, Research Funding; BMS: Research Funding; IMARA COMPANY: Research Funding; NOVARTIS COMPANY: Research Funding. Voskaridou:  BMS: Consultancy, Research Funding; IMARA: Research Funding; NOVARTIS: Research Funding; ADDMEDICA: Consultancy, Research Funding; GENESIS: Consultancy, Research Funding; PROTAGONIST: Research Funding. Biemond:  GBT: Honoraria, Research Funding, Speakers Bureau; Novartis: Honoraria, Research Funding, Speakers Bureau; Novo Nordisk: Honoraria; Celgene: Honoraria; Sanquin: Research Funding. Nur:  Celgene: Speakers Bureau; Roche: Speakers Bureau; Novartis: Research Funding, Speakers Bureau. Beneitez-Pastor:  Agios: Honoraria; Alexion: Honoraria; Novartis: Honoraria; Forma Therapeutics: Honoraria. Pepe:  Chiesi Farmaceutici S.p.A: Other: no profit support; Bayer S.p.A.: Other: no profit support. de Montalembert:  Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees; Addmedica: Membership on an entity's Board of Directors or advisory committees; BlueBirdBio: Membership on an entity's Board of Directors or advisory committees; Vertex: Membership on an entity's Board of Directors or advisory committees. Glenth\u00f8j:  Agios: Consultancy; Novo Nordisk: Honoraria; Novartis: Consultancy; Alexion: Research Funding; Bluebird Bio: Consultancy; Bristol Myers Squibb: Consultancy; Saniona: Research Funding; Sanofi: Research Funding. Benghiat:  Novartis: Consultancy; BMS: Consultancy. Labarque:  Novartis: Consultancy; Bayer: Consultancy; Sobi: Consultancy; NovoNordisk: Consultancy; Octapharma: Consultancy. Diamantidis:  Genesis Pharma: Honoraria; Uni-Pharma: Honoraria; Bristol Myers Squibb: Consultancy; IONIS Pharmaceuticals: Research Funding; NOVARTIS, Genesis Pharma SA: Research Funding. Kerkhoffs:  Sanofi: Research Funding; Terumo BCT: Research Funding. Iolascon:  Celgene: Other: Advisory Board; Bluebird Bio: Other: Advisory Board. Taher:  Vifor Pharma: Consultancy, Research Funding; Agios Pharmaceuticals: Consultancy; Ionis Pharmaceuticals: Consultancy, Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; Novartis: Consultancy, Research Funding. Colombatti:  Novartis: Membership on an entity's Board of Directors or advisory committees; Global Blood Therapeutics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Novonordisk: Membership on an entity's Board of Directors or advisory committees; Forma Therapeutics: Membership on an entity's Board of Directors or advisory committees; Addmedica: Membership on an entity's Board of Directors or advisory committees; BlueBirdBio: Research Funding. Ma\u00f1\u00fa Pereira:  Novartis: Research Funding; Agios Pharmaceuticals: Research Funding.",
    "author_names": [
        "Pablo Velasco",
        "Filomena Longo",
        "Andrea Piolatto",
        "Eduardo J. Bard\u00f3n-Cancho",
        "Beatriz Ponce-Salas",
        "Pagona Flevari",
        "Ersi Voskaridou",
        "Bart J. Biemond",
        "Erfan Nur",
        "Polyxeni Delaporta",
        "Tatiana Besse-Hammer",
        "Anna Ruiz-Llobet",
        "Simona Raso",
        "Anna Spasiano",
        "Maria Elena Guerzoni",
        "David Beneitez-Pastor",
        "Laurence Dedeken",
        "Alessia Pepe",
        "Rosamaria Rosso",
        "Joachim B. Kunz",
        "Mariane de Montalembert",
        "Saveria Campisi",
        "Andreas Glenth\u00f8j",
        "Paula Gonzalez Urdiales",
        "Fleur Samantha Benghiat",
        "Marie-Agn\u00e8s Azerad",
        "Christopher J. Saunders",
        "Teresa Ferreira Faria",
        "Tommaso Casini",
        "Sabrina Bagnato",
        "Ann Van de Velde",
        "Veerle Labarque",
        "Elisa Bertoni",
        "An Van Damme",
        "Michael D. Diamantidis",
        "Roberta Russo",
        "Eftichia Stiakaki",
        "Alessandra Quota",
        "Soteroula Christou",
        "Maria Jose Teles",
        "Ioannis Lafiatis",
        "Jean-Louis Kerkhoffs",
        "Mar\u00eda Arg\u00fcello Marina",
        "Mikael Lorite",
        "Alexis Rodriguez",
        "Achille Iolascon",
        "Ali T. Taher",
        "Raffaella Colombatti",
        "Noemi Roy",
        "Maria Del Mar Ma\u00f1\u00fa Pereira"
    ],
    "author_dict_list": [
        {
            "author_name": "Pablo Velasco",
            "author_affiliations": [
                "Pediatric Oncology and Hematology, Vall d'Hebron Hospital Universitari, Barcelona, Spain",
                "Pediatric Department, UAB ( Universitat Aut\u00f2noma de Barcelona) College, Barcelona, Spain"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Filomena Longo",
            "author_affiliations": [
                "Department of Clinical and Biological Sciences, University of Torino, Orbassano (To), Italy"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrea Piolatto",
            "author_affiliations": [
                "Department of Clinical and Biological Sciences, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eduardo J. Bard\u00f3n-Cancho",
            "author_affiliations": [
                "Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain",
                "Pediatric Hematology Unit, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain",
                "Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Beatriz Ponce-Salas",
            "author_affiliations": [
                "Onco-Hematolog\u00eda Infantil, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pagona Flevari",
            "author_affiliations": [
                "Center of Excellence in Rare Haematological Diseases-Haemoglobinopathies, Laiko General Hospital, Athens, Greece"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ersi Voskaridou",
            "author_affiliations": [
                "Center of Excellence in Rare Haematological Diseases-Haemoglobinopathies, Laiko General Hospital, Athens, Greece"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bart J. Biemond",
            "author_affiliations": [
                "Department of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Erfan Nur",
            "author_affiliations": [
                "Department of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands",
                "Department or Blood Cell Research, Sanquin Research, Amsterdam, Netherlands"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Polyxeni Delaporta",
            "author_affiliations": [
                "First Department of Pediatrics, National and Kapodistrian University of Athens, 'Aghia Sophia' Children's Hospital, Athens, Greece"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tatiana Besse-Hammer",
            "author_affiliations": [
                "URC, CHU Brugmann, Brussels, Belgium"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Ruiz-Llobet",
            "author_affiliations": [
                "Paediatric Haematology Department, Hospital Sant Joan de D\u00e9u, Universitat de Barcelona, Barcelona, Spain"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Simona Raso",
            "author_affiliations": [
                "Department of Hematology and Rare Diseases, V Cervello, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Spasiano",
            "author_affiliations": [
                "Malalttie Rare del Globulo Rosso, AORN A. Cardarelli, Naples, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Elena Guerzoni",
            "author_affiliations": [
                "Pediatric Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "David Beneitez-Pastor",
            "author_affiliations": [
                "Translational Research Group in Rare Anemia Disorders, Vall d'Hebron Institut de Recerca, Barcelona, Spain",
                "Hematology Department, Vall d'Hebron Hospital Universitari, Barcelona, Spain",
                "Experimental Hematology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain",
                "Vall d'Hebron Hospital Universitari, ERN-EuroBloodNet, Barcelona, Spain"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Laurence Dedeken",
            "author_affiliations": [
                "H\u00f4pital Universitaire des Enfants Reine Fabiola (ULB), Brussels, Belgium"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessia Pepe",
            "author_affiliations": [
                "Fondazione Toscana G. Monasterio per la ricerca medica e di sanit\u00e0 pubblica, Pisa, Italy"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rosamaria Rosso",
            "author_affiliations": [
                "Thalassemia and Heamoglobinophaties, Policlinico Universitario G. Rodolico, Catania, Italy"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joachim B. Kunz",
            "author_affiliations": [
                "University Hospital Heidelberg, Heidelberg, Germany"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mariane de Montalembert",
            "author_affiliations": [
                "H\u00f4pital Necker, Paris, France"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Saveria Campisi",
            "author_affiliations": [
                "Ospedale Umberto I, Siracusa, Italy"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andreas Glenth\u00f8j",
            "author_affiliations": [
                "Department of Hematology, Rigshospitalet, Copenhagen, Denmark"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paula Gonzalez Urdiales",
            "author_affiliations": [
                "Pediatric oncology and hematology department, Hospital Universitario Cruces, Barakaldo, Spain",
                "Instituto de investigaci\u00f3n Biocruces Bizkaia, Barakaldo, Spain"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fleur Samantha Benghiat",
            "author_affiliations": [
                "CUB Erasmus hospital, Brussels, Belgium"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marie-Agn\u00e8s Azerad",
            "author_affiliations": [
                "Hematology, CHU Li\u00e8ge Citadelle site, Li\u00e8ge, Belgium"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christopher J. Saunders",
            "author_affiliations": [
                "Hospital dos Capuchos, Centro Hospitalar e Universit\u00e1rio Lisboa Central, Lisbon, Portugal"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Teresa Ferreira Faria",
            "author_affiliations": [
                "Pediatric Department, Hospital Fernando Fonseca, Amadora, Portugal"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tommaso Casini",
            "author_affiliations": [
                "Pediatric OncoHematology, Meyer Children Hospital, Florence, Italy"
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sabrina Bagnato",
            "author_affiliations": [
                "Thalassemia, Ospedale Civile, Lentini, Italy"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ann Van de Velde",
            "author_affiliations": [
                "Hematology, University Hospital Antwerp, Edegem, Belgium"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Veerle Labarque",
            "author_affiliations": [
                "Pediatric Hemato-Oncology, University Hospitals Leuven, Leuven, Belgium"
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisa Bertoni",
            "author_affiliations": [
                "Oncohaematology and BMT Unit, ASST Spedali Civili di Brescia, Brescia, Italy"
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "An Van Damme",
            "author_affiliations": [
                "Paediatric H\u00e9mato-oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium"
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michael D. Diamantidis",
            "author_affiliations": [
                "Thalassemia and Sickle Cell Disease Unit, Department of Hematology, General Hospital of Larissa, Larissa, Greece"
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberta Russo",
            "author_affiliations": [
                "Department of Molecular Medicine and Medical Biotechnology, University Federico II, Naples, Italy",
                "CEINGE - Advanced Biotechnologies, Naples, Italy"
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eftichia Stiakaki",
            "author_affiliations": [
                "Pediatric Hematology-Oncology Department, University of Crete, University Hospital of Heraklion, Heraklion, Greece"
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Quota",
            "author_affiliations": [
                "UOSD Thalassemia, V.Emanuele Hospital, Gela, Italy"
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Soteroula Christou",
            "author_affiliations": [
                "Thalassemia Clinic, Archbishop Makarios III Hospital, Nicosia, Cyprus"
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Jose Teles",
            "author_affiliations": [
                "Clinical Pathology, Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal",
                "Clinical Hematology, Centro Hospitalar e Universit\u00e1rio do Porto, Porto, Portugal",
                "Anemia Working Group Portugal, Porto, Portugal",
                "Institute for the Health Research and Innovation (i3S), Porto, Portugal",
                "Hematology Working Group of the Portuguese Society of Clinical Pathology, Porto, Portugal"
            ],
            "author_rank": 40,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ioannis Lafiatis",
            "author_affiliations": [
                "General Hospital of Mytilini, Mytilini, Greece"
            ],
            "author_rank": 41,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jean-Louis Kerkhoffs",
            "author_affiliations": [
                "Hematology, HagaZiekenhuis, The Hague, Netherlands"
            ],
            "author_rank": 42,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mar\u00eda Arg\u00fcello Marina",
            "author_affiliations": [
                "Hematology, Hospital Pr\u00edncipe de Asturias, Madrid, Spain"
            ],
            "author_rank": 43,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mikael Lorite",
            "author_affiliations": [
                "Department of pediatric Hematology, Hospital Son Espases, Palma de Mallorca, Spain"
            ],
            "author_rank": 44,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alexis Rodriguez",
            "author_affiliations": [
                "Clinical Pharmacology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain",
                "Vall d'Hebron Institut de Recerca, Barcelona, Spain"
            ],
            "author_rank": 45,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Achille Iolascon",
            "author_affiliations": [
                "Department of Molecular Medicine and Medical Biotechnology, University Federico II, Naples, Italy",
                "CEINGE - Advanced Biotechnologies, Naples, Italy"
            ],
            "author_rank": 46,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ali T. Taher",
            "author_affiliations": [
                "Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon"
            ],
            "author_rank": 47,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raffaella Colombatti",
            "author_affiliations": [
                "UOC Pediatric Hematology Oncology, University of Padova, Padova, Italy"
            ],
            "author_rank": 48,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Noemi Roy",
            "author_affiliations": [
                "Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"
            ],
            "author_rank": 49,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Del Mar Ma\u00f1\u00fa Pereira",
            "author_affiliations": [
                "Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca, Barcelona, Spain"
            ],
            "author_rank": 50,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-21T13:00:11",
    "is_scraped": "1"
}